drugset / Trial / NCT00634933
Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the efficacy and safety of two dosing regimens of a compound known as TRU-015 in combination with methotrexate (MTX) in patients with active rheumatoid arthritis.
Timeline
- Start
- 2008-03
- Primary completion
- 2010-02
- Completion
- 2012-10
Outcome
Outcome not reported
Stopped: “The study was terminated on 21 June 2010 due to results not meeting the primary endpoint. No safety reasons contributed to the termination of the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TRU-015 | Unknown | 800 mg | Intravenous |
| Comparator | Methylprednisolone | Other / unclassified | 100 mg | Intravenous |
| Comparator | Prednisone | Other / unclassified | 20 mg | Oral |